证券代码：301108 证券简称：洁雅股份 公告编号：2023-048 铜陵洁雅生物科技股份有限公司 关于与专业投资机构共同投资的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 一、与专业投资机构共同投资概述 1、基本情况 为促进铜陵洁雅生物科技股份有限公司（以下简称"公司"）长远发展，充 分借助专业投资机构的力量及资源优势，进一步拓宽公司行业领域及提升综合竞 争力，在不影响公司日常经营发展、有效控制投资风险的前提下，公司拟与厦门 琢石明玉私募基金管理有限公司（以下简称"琢石明玉"）、铜陵高新科技发展 有限公司（以下简称"高新科技"）、自然人彭松共同投资设立铜陵市雅石共赏 美妆健康股权投资合伙企业（有限合伙）（以下简称"雅石共赏"或"合伙企业"， 暂定名，最终名称以市场监督管理机构登记核定的为准）。合伙企业的总认缴出 资额为 10,200 万元人民币，其中，公司作为有限合伙人拟以自有资金认缴出资 额 8,000 万元人民币、琢石明玉作为普通合伙人认缴出资额 100 万元人民币、高 新科技作为有限合伙人认缴出资额 2,000 万元人民币、彭松作为有限合伙人 ...

Group 1: Financial Performance - The main reason for the decline in the company's performance in the first half of 2023 was a decrease in orders for disinfectant wipes, which has now returned to pre-pandemic levels, and the impact has been largely eliminated [2] - Revenue from facial mask products decreased by 2.6676 million yuan year-on-year in the first half of 2023, primarily due to supply and demand issues in the foot mask market [2] - The company's gross profit margin in the second quarter was lower than in the first quarter due to compensation payments from disinfectant wipe customers in the first quarter, resulting in a higher gross margin for that period [2] Group 2: Operational Insights - The order-to-delivery cycle for products is approximately 45 days [2] - There has been little fluctuation in the price of non-woven fabric this year, indicating stable raw material costs [2] - The company has seen a year-on-year decrease in foreign exchange gains compared to last year [2] Group 3: Strategic Developments - The company plans to leverage its manufacturing advantages to better serve its customers, focusing on its own brand development [2] - In August 2023, the company obtained two Class II medical device registration certificates, and it is currently applying for a medical device production license [2] Group 4: Compliance and Governance - The investor communication activity adhered strictly to the Shenzhen Stock Exchange's self-regulatory guidelines, with no incidents of undisclosed material information leakage [2]

证券代码:301108 证券简称:洁雅股份 编号:2023-023 | --- | --- | --- | |----------------|--------------|------------| | | 特定对象调研 | 分析师会议 | | | □媒体采访 | 业绩说明会 | | 投资者关系活动 | | | | | □新闻发布会 | □路演活动 | | 类别 | | | 现场参观 其他 2023 年安徽辖区上市公司投 资者网上集体接待日活动 参与单位名称及 线上参与2023年安徽辖区上市公司投资者网上集体接待日活动的 人员姓名 中小投资者及机构投资者 时间 2023 年 9 月 12 日 15:30-17:30 公司通过全景网"投资者关系互动平台"(https://ir.p5w.net) 地点 采 用 网 络 远 程 的 方 式 召 开 业 绩 说 明 会 " 全 景 路 演 " (http://rs.p5w.net) 副总经理、董事会秘书:胡能华先生 上市公司接待人 董事、财务总监:杨凡龙先生 员姓名 证券事务代表:徐文丽 公司于 2023 年 9 月 12 日(星期二)下午 15:30-17:30 ...

Group 1: Event Details - The company will participate in the "2023 Anhui Listed Companies Investor Online Reception Day" [1] - The event will be held online on September 12, 2023, from 15:30 to 17:30 [1] - Investors can join via the "Panorama Roadshow" website, WeChat public account, or the Panorama Roadshow APP [1] Group 2: Communication Focus - Company executives will discuss the 2023 half-year performance, corporate governance, development strategy, operational status, financing plans, equity incentives, and sustainable development [1] - The event aims to enhance interaction and communication with investors [1] Group 3: Assurance of Information - The company and its board guarantee the authenticity, accuracy, and completeness of the disclosed information, with no false records or misleading statements [1]

证券代码:301108 证券简称:洁雅股份 编号:2023-022 | --- | --- | |------------|--------------| | | 特定对象调研 | | 投资者关系 | □媒体采访 | | 活动类别 | □新闻发布会 | | | 现场参观 | 【财通证券】:余剑秋、王宇璇;【兴业证券】:侯宜芳;【歌 斐资产】:吴晋恺;【歌汝私募】:郝朋哲;【融通基金】:许 富强;【方正富邦】:柳政甫;【汇添富】:李泽昱;【华安资 参与单位名称 产】:李亚鑫;【华商基金】:常宁;【华安证券】:马远方、 及人员姓名 黄玺;【人保资管】:叶一非;【兴合基金】:孙祺;【兴银基 金】:孔晓语;【汇丰晋信】:赵洋;【睿郡资产】:谭一苇; 【农银汇理】:周宇;【东方基金】:张博。 时间 2023 年 8 月 30 日 10:00-10:40、20:00-20:40 地点 铜陵市狮子山经济开发区地质大道 528 号 铜陵洁雅生物科技股份有限公司证券部办公室 副总经理、董事会秘书:胡能华 上市公司接待 董事、财务总监:杨凡龙 人员姓名 证券事务代表:徐文丽 一、公司基本情况介绍: 铜陵洁雅生物科技股份有限公司成 ...

Financial Performance - The company reported a significant increase in revenue for the first half of 2023, with total revenue reaching RMB 500 million, representing a year-on-year growth of 25%[14]. - The company's operating revenue for the reporting period was ¥279,518,635.92, a decrease of 22.26% compared to the same period last year[21]. - The net profit attributable to shareholders was ¥65,100,732.11, down 26.98% year-over-year[21]. - The net profit after deducting non-recurring gains and losses was ¥52,794,367.35, reflecting a decline of 39.02% compared to the previous year[21]. - The net cash flow from operating activities was ¥45,989,066.50, a significant drop of 67.00% from the same period last year[21]. - The gross profit margin for wet wipes was 26.65%, down 2.25% year-on-year, with revenue from wet wipes decreasing by 26.06%[48]. - The company reported a net profit margin of 12%, reflecting a stable financial performance amidst market challenges[96]. - The total profit for the first half of 2023 was CNY 74.33 million, a decrease of 27.4% from CNY 102.40 million in the first half of 2022[170]. - The company reported a comprehensive income total of CNY 64.99 million for the first half of 2023, compared to CNY 89.16 million in the same period of 2022[174]. Market Expansion and Product Development - User data indicates that the active customer base has expanded to 1.2 million, an increase of 15% compared to the previous year[14]. - New product launches contributed to 30% of total sales, with the introduction of three innovative hygiene products in the first half of 2023[14]. - The company has set a revenue guidance for the second half of 2023, projecting a growth rate of 20% year-on-year, aiming for a total revenue of RMB 600 million[14]. - The company is actively exploring potential acquisitions to bolster its product portfolio and market presence[14]. - The company is expanding its market presence in Southeast Asia, targeting a 25% market share by the end of 2024[97]. - New product launches are expected to contribute an additional CNY 200 million in revenue by Q4 2023[97]. - The company has plans for market expansion and new product development to drive future growth[182]. Research and Development - The company is investing RMB 50 million in R&D for new technologies aimed at enhancing product efficiency and sustainability[14]. - Research and development expenses increased by 30%, totaling CNY 150 million, focusing on innovative biotechnologies[97]. - The company has a strong R&D team capable of independently developing core technologies for wet wipe solutions, supported by advanced research and testing equipment[41]. - The company has established a comprehensive procurement control procedure, ensuring high-quality raw materials, with non-woven fabric being a significant portion of procurement costs[36]. Financial Management and Investments - The total amount of raised funds is RMB 1,162,721,769.66, with a net amount of RMB 1,031,831,424.91 after deducting issuance costs[63]. - The company reported a significant increase in total investment amounting to ¥1,022,163,907.33, a 180.78% rise compared to ¥364,040,216.54 in the previous year[56]. - The net cash flow from investing activities was -¥625,664,006.27, a 99.67% increase in outflow compared to -¥313,355,216.54 last year, primarily due to increased investments in financial products[46]. - The company has committed 42,244.08 million of its own funds and 39,900 million of raised funds to bank wealth management products, totaling 102,144.08 million in entrusted wealth management[74]. Risk Management - Risk management strategies have been outlined to address potential market fluctuations and operational challenges[3]. - The company faces risks related to technology research and development, particularly in the wet wipes industry, and plans to increase R&D investment and enhance team building[82]. - The company is exposed to raw material price fluctuation risks, which significantly impact operating performance, and will strengthen strategic cooperation with suppliers[84]. - The company has a high customer concentration risk, relying on major clients like Woolworths and Johnson & Johnson, and aims to diversify its customer base[85]. Corporate Governance and Compliance - The company has not reported any issues or other circumstances regarding the use and disclosure of raised funds[69]. - The company has maintained a good credit status, with no overdue debts or unfulfilled commitments[124]. - There were no significant related party transactions during the reporting period[125]. - The financial statements are prepared in accordance with the enterprise accounting standards, reflecting the company's financial status and operating results accurately[200]. Shareholder Information - The company reported a total of 10,153 shareholders at the end of the reporting period[147]. - The largest shareholder, Cai Yingchuan, holds 52.88% of the shares, totaling 42,946,052 shares[147]. - The proportion of limited sale shares decreased from 57.19% to 56.82%, while the proportion of unrestricted sale shares increased from 42.81% to 43.18%[142]. Environmental and Social Responsibility - The company has taken measures to reduce carbon emissions, including the procurement of new energy vehicles and the establishment of distributed photovoltaic power stations[109]. - The company has achieved dual certification for environmental management (ISO 14001:2015) and occupational health and safety management (ISO 45001:2018)[112][113].

证券代码：301108 证券简称：洁雅股份 公告编号：2023-041 铜陵洁雅生物科技股份有限公司 第五届监事会第十一次会议决议公告 经审议，公司监事会认为：公司《2023 年半年度报告》及《2023 年半年度 报告摘要》真实反映了公司 2023 年半年度的财务状况和经营成果，符合法律、 行政法规、中国证监会和深圳证券交易所的相关规定，报告内容真实、准确，完 整，不存在任何虚假记载、误导性陈述或者重大遗漏。 具体内容详见公司同日披露于巨潮资讯网（http://www.cninfo.com.cn）的 《2023 年半年度报告》及《2023 年半年度报告摘要》。 表决结果：3 票同意，0 票反对，0 票弃权。 三、备查文件 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 铜陵洁雅生物科技股份有限公司（以下简称"公司"）第五届监事会第十一 次会议于 2023 年 8 月 28 日以通讯方式召开。会议通知于 2023 年 8 月 18 日以电 子邮件方式发出。本次监事会应出席监事 3 人，实际出席监事 3 人（全体监事以 通讯表决方式出席）。 ...

铜陵洁雅生物科技股份有限公司 2023 年半年度非经营性资金占用及其他关联资金往来情况汇总表 法定代表人：蔡英传 主管会计工作负责人：杨凡龙 会计机构负责人（会计主管人员）：杨凡龙 单位：万元 非经营性资金占用 资金占用方 名称 占用方与上 市公司的关 联关系 上市公司核算 的会计科目 2023 年期初 占用资金余 额 2023 年 1-6 月占 用累计发生金额 （不含利息） 2023 年 1-6 月 占用资金的利 息（如有） 2023 年 1-6 月偿还累计 发生金额 2023年 6月 末占用资金 余额 占用形 成原因 占用性质 控股股东、实际控制人及 其附属企业 非经营性占用 非经营性占用 小计 - - - - 前控股股东、实际控制人 及其附属企业 非经营性占用 非经营性占用 小计 - - - - 其他关联方及附属企业 非经营性占用 小计 总计 - - - - 其它关联资金往来 资金往来方 名称 往来方与上 市公司的关 联关系 上市公司核算 的会计科目 2023 年期初 往来资金余 额 2023 年 1-6 月往 来累计发生金额 （不含利息） 2023 年 1-6 月 往来资金的利 息（如有） 2023 ...

铜陵洁雅生物科技股份有限公司 证券代码：301108 证券简称：洁雅股份 公告编号：2023-043 铜陵洁雅生物科技股份有限公司 关于 2023 年半年度募集资金存放与使用情况的专项报告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 铜陵洁雅生物科技股份有限公司（以下简称"公司"）根据《上市公司监管 指引第 2 号——上市公司募集资金管理和使用的监管要求》《深圳证券交易所上 市公司自律监管指引第 2 号——创业板上市公司规范运作》及《深圳证券交易所 创业板上市公司自律监管指南第 2 号——公告格式》的规定，编制了 2023 年半 年度募集资金存放与使用情况报告如下： 一、募集资金基本情况 （一）实际募集资金金额和资金到账时间 铜陵洁雅生物科技股份有限公司 产品余额 59,900 万元，募集资金账户余额为人民币 23,527.52 万元（含利息）。 二、募集资金存放和管理情况 为了规范募集资金的管理和使用，提高资金使用效率和效益，保护投资者权 益，公司根据《中华人民共和国公司法》《中华人民共和国证券法》《深圳证券 交易所创业板股票上市规则》及《深圳证券交易所 ...

一、董事会会议召开情况 铜陵洁雅生物科技股份有限公司（以下简称"公司"）第五届董事会第十三 次会议于 2023 年 8 月 28 日以通讯方式召开，本次会议通知已于 2023 年 8 月 18 日通过电子邮件的方式送达全体董事。本次会议应出席董事 9 人，实际出席董事 9 人（全体董事以通讯表决方式出席）。本次会议由董事长兼总经理蔡英传先生 主持，本次董事会会议的召开符合《中华人民共和国公司法》等有关法律、行政 法规、部门规章、规范性文件及《公司章程》的规定。 二、董事会会议审议情况 经各位董事认真审议，形成了如下决议： 1、审议通过《关于<公司 2023 年半年度报告>及摘要的议案》 证券代码：301108 证券简称：洁雅股份 公告编号：2023-040 铜陵洁雅生物科技股份有限公司 第五届董事会第十三次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 2、审议通过《关于<2023 年半年度募集资金存放与使用情况的专项报告> 的议案》 经审议，董事会认为公司 2023 年半年度募集资金存放与使用情况符合《上 市公司监管指引第 2 号——上市公司募 ...